| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 3835 |
| 1 | PREDNISONE | 3181 |
| 2 | IPILIMUMAB | 2337 |
| 3 | NIVOLUMAB | 2300 |
| 4 | METHOTREXATE SODIUM | 1882 |
| 5 | ACETAMINOPHEN | 1740 |
| 6 | INFLIXIMAB | 1737 |
| 7 | METHOTREXATE | 1695 |
| 8 | ASPIRIN | 1459 |
| 9 | ASPIRIN 325 MG | 1424 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CUPRIC OXIDE | 62 | 0.1400 |
| 1 | DIMETHYL SULFOXIDE | 23 | 0.0947 |
| 2 | MINERAL SUNSHIELD UNIVERSAL TINT BROAD SPECTRUM SPF 30 SUNSCREEN | 151 | 0.0764 |
| 3 | ZINC OXIDE OINTMENT | 151 | 0.0752 |
| 4 | ZINC OXIDE | 151 | 0.0718 |
| 5 | GLYCERIN SUPPOSITORY | 171 | 0.0645 |
| 6 | GLYCERIN SUPPOSITORIES | 170 | 0.0632 |
| 7 | SKIN PROTECTANT | 157 | 0.0587 |
| 8 | IPILIMUMAB | 2337 | 0.0533 |
| 9 | TREMELIMUMAB | 194 | 0.0438 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 6533 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 3590 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 2749 |
| 3 | CTLA-4-directed Blocking Antibody [EPC] | 2511 |
| 4 | Platinum-based Drug [EPC] | 2329 |
| 5 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 2313 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 2145 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 2019 |
| 8 | Proton Pump Inhibitor [EPC] | 1948 |
| 9 | Benzodiazepine [EPC] | 1883 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CTLA-4-directed Blocking Antibody [EPC] | 2511 | 0.0521 |
| 1 | Interferon gamma Blocker [EPC] | 7 | 0.0295 |
| 2 | Lymphocyte Activation Gene-3 Blocker [EPC] | 13 | 0.0252 |
| 3 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 2313 | 0.0235 |
| 4 | Sclerosing Agent [EPC] | 10 | 0.0222 |
| 5 | l-Triiodothyronine [EPC] | 1 | 0.0196 |
| 6 | Human Immunoglobulin [EPC] | 1 | 0.0196 |
| 7 | Programmed Death Ligand-1 Blocker [EPC] | 400 | 0.0185 |
| 8 | Nitroimidazole Antimicrobial [EPC] | 1144 | 0.0173 |
| 9 | Stimulant Laxative [EPC] | 248 | 0.0172 |